Beyond neutralization, antibodies drive antiviral control via Fc-mediated functions
Distinct vaccines elicit unique antibody Fc-effector profiles
Network analyses comprehensively integrating antibody profiles can compare vaccines
Case:control RV144 analysis points to mechanisms of reduced risk of HIV infection